Market Cap 394,000.00
Revenue (ttm) 6.99M
Net Income (ttm) -45.22M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -646.92%
Debt to Equity Ratio 0.00
Volume 317,596
Avg Vol 928,248
Day's Range N/A - N/A
Shares Out 5.79M
Stochastic %K 10%
Beta 0.88
Analysts Strong Sell
Price Target $5.00

Company Profile

Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, te...

Industry: Biotechnology
Sector: Healthcare
Phone: 919 240 7133
Address:
1305 East Houston Street, San Antonio, United States
Latest News on SCPX
No data available.